HARP - Harpoon Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HARP is currently covered by 6 analysts with an average price target of $39.42. This is a potential upside of $16.41 (71.32%) from yesterday's end of day stock price of $23.01.

Harpoon Therapeutics's activity chart (see below) currently has 51 price targets and 53 ratings on display. The stock rating distribution of HARP is 38.46% HOLD and 61.54% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.11% with an average time for these price targets to be met of 114 days.

Highest price target for HARP is $23, Lowest price target is $12, average price target is $39.42.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 26-Feb-2024. First documented stock forecast 05-Mar-2019.

Currently out of the existing stock ratings of HARP, 5 are a HOLD (38.46%), 8 are a BUY (61.54%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$23

$-0.01 (-0.04%)

$13

8 months 27 days ago
(26-Feb-2024)

4/9 (44.44%)

$0.07 (0.31%)

165

Hold

$23

$-0.01 (-0.04%)

$20

10 months 13 days ago
(09-Jan-2024)

4/5 (80%)

$0.64 (2.86%)

215

Hold

$23

$-0.01 (-0.04%)

$12

10 months 14 days ago
(08-Jan-2024)

3/4 (75%)

$0.64 (2.86%)

43

Buy

$12

$-11.01 (-47.85%)

11 months 9 days ago
(13-Dec-2023)

1/2 (50%)

$2.54 (26.85%)

9

Buy

$70

1 years 7 months 22 days ago
(31-Mar-2023)

0/5 (0%)

$50 (250.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HARP (Harpoon Therapeutics) average time for price targets to be met?

On average it took 114 days on average for the stock forecasts to be realized with a an average price target met ratio 44.11

Which analyst has the current highest performing score on HARP (Harpoon Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on HARP (Harpoon Therapeutics)?

Yigal Nochomovitz works at CITI and has 17 price targets and 9 ratings on HARP

Which analyst is the currently most bullish on HARP (Harpoon Therapeutics)?

Zegbeh Jallah with highest potential upside - $116.99

Which analyst is the currently most reserved on HARP (Harpoon Therapeutics)?

Robert Driscoll with lowest potential downside - -$16.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?